• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Dexamethasone down-regulates Th1 cells by modulating T-cell immune response cDNA7 in acute immune th

Dexamethasone down-regulates Th1 cells by modulating T-cell immune response cDNA7 in acute immune th

来源 :第十五届全国实验血液学学术会议 | 被引量 : 0次 | 上传用户：jonquil1981
【摘 要】
：
Objective T-cell immune response cDNA 7(TIRC7) has been identified and demonstrated to be essential in T cell activation.However, the role of TIRC7 in acute immune thrombocytopenia (ITP) re mains poor
【作 者】
：
Feng Zhu 
【机 构】
：
the affiliated hospital of Xuzhou Medical College Department of hematology
【出 处】
：
第十五届全国实验血液学学术会议
【发表日期】
：
2015年3期
【关键词】
：
Dexamethasone acute immune thrombocytopenia Th1 cells T-cell immune response cDN 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Objective T-cell immune response cDNA 7(TIRC7) has been identified and demonstrated to be essential in T cell activation.However, the role of TIRC7 in acute immune thrombocytopenia (ITP) re mains poorly understood.This study aimed to investigate the expression levels of TIRC7 and T helper (Th) cells in acute ITP patients before and after dexamethasone and abscertain if dexamethasone down-regulates the levels of Th 1 cells by modulating TIRC7 in ITP.
其他文献
急性髓系白血病中ID1基因表达的临床意义
目的 检测急性髓系白血病(acute myeloid leukemia,AML)患者骨髓中ID1 (inhibitors of differentiation 1)基因的表达并探讨其临床意义.方法 收集102例AML患者和28例健康者骨髓,应用实时定量PCR (real-time quantitative PCR,RQ-PCR)方法检测骨髓单个核细胞(bone marrow mononuclear
会议
ID1expressionprognosisAML
Effect of adding gemtuzumab ozogamicin to induction chemotherapy for newly diagnosed acute myeloid l
Background Gemtuzumab ozogamicin (GO) is a targeted antineoplastic agent comprised of a recombinant anti-CD33 humanized antibody linked to calicheamicin.Previous trials have showed conflicting results
会议
gemtuzumab ozogamicininduction chemotherapyacute myeloid leukemia
Idarubicin compared to other anthracyclines for newly diagnosed acute myeloid leukaemia
Background and Objective There is no evidence that would definitively prove the superiority of IDA versus other anthracyclines in induction therapy of newly diagnosed acute myeloid leukemia (AML).We p
会议
Idarubicinacute myeloid leukaemia
High doses of daunorubicin during induction therapy of newly diagnosed acute myeloid leukemia: a sys
The right dose of daunorubicin (DNR) for the treatment of newly diagnosed acute myeloid leukemia (AML)is uncertain.Previous trials have shown conflicting results concerning the efficacy of high or low
会议
High doses of daunorubicininduction therapyacute myeloid leukemia
Cyclosporine A versus Tacrolimus as Immunosuppressive Therapy after Allogeneic Hematopoietic Stem Ce
Background and Objective Cyclosporine A (CsA) has been used as immunosuppressive therapy after allogeneic hematopoietic stem cell transplantation (HSCT) for about 30 years.Recently, Tacrolimus (FK506)
会议
Cyclosporine ATacrolimusAllogeneic Hematopoietic Stem Cell Transplantation
High-dose cytarabine for consolidation therapy of acute myeloid leukemia in first complete remission
Background New evidence has questioned the role of high-dose cytarabine (HDAC) in consolidation therapy of acute myeloid leukemia (AML) in first complete remission (CR1).We performed a meta-analysis t
会议
High-dose cytarabineconsolidation therapyacute myeloid leukemia
Co-transplantation with mesenchymal stem cells expressing a SDF-1/HOXB4 fusion protein markedly impr
Introduction Mesenchymal stem cells (MSCs) contribute to the engraftment of transplanted hematopoietic stem cells (HSCs).MSCs also accelerate hematological recovery by secreting SDF-1 and enabling HSC
会议
SDF-1/HOXB4hematopoietic stem cellirradiated mice
The effects of allogeneic stem cell transplantation with matched sibling donor versus autologous ste
Background Multiple myeloma (MM) is a malignant proliferative disease which is characterized by excessive proliferation of abnormal plasma cell originated from post-germinal-center B cells.The choice
会议
The effects of allogeneic stem cell transplantation with matched sibling donor v
Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocy
Objective Previously, we demonstrated the importance ofT-cell immune response cDNA 7 (TIRC7) in acute i mmune thrombocytopenia (ITP).As the downstream molecule of TIRC7, cytotoxic T lymphocyte antigen
会议
acute immune thrombocytopenia(ITP)cytotoxic T lymphocyte antigen-4(CTLA-4)immu
Comparison of Total Body Irradiation with Busulfan/Cyclophosphamide on the Development of Hepatic Ve
Aims To evaluate and compare the effect of total body irradiation (TBI) with busulfan/cyclophosphamide (BU/CY) as conditioning regimen on the development of hepatic veno-occlusive disease (HVOD) occur
会议
Hematopoietic Stem Cell TransplantationHepatic Veno-Occlusive Disease